Autocrine Signaling of NRP1 Ligand Galectin-1 Elicits Resistance to BRAF-Targeted Therapy in Melanoma Cells.

MLA

Rizzolio, Sabrina, et al. “Autocrine Signaling of NRP1 Ligand Galectin-1 Elicits Resistance to BRAF-Targeted Therapy in Melanoma Cells.” Cancers, vol. 12, no. 8, Aug. 2020. EBSCOhost, https://doi.org/10.3390/cancers12082218.

APA

Rizzolio, S., Corso, S., Giordano, S., & Tamagnone, L. (2020). Autocrine Signaling of NRP1 Ligand Galectin-1 Elicits Resistance to BRAF-Targeted Therapy in Melanoma Cells. Cancers, 12(8). https://doi.org/10.3390/cancers12082218

Chicago

Rizzolio, Sabrina, Simona Corso, Silvia Giordano, and Luca Tamagnone. 2020. “Autocrine Signaling of NRP1 Ligand Galectin-1 Elicits Resistance to BRAF-Targeted Therapy in Melanoma Cells.” Cancers 12 (8). doi:10.3390/cancers12082218.